Camelot Portfolios’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-6,370
Closed -$292K 193
2017
Q1
$292K Buy
+6,370
New +$317K 0.14% 137

Other funds holding SYNH

Camelot Portfolios's SYNH Position: Q2 2017 in Review

Camelot Portfolios sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q2 2017, closing a stake of 6,370 shares — an estimated $292K sold.

Camelot Portfolios first reported a position in SYNH in Q1 2017 and held it in 1 quarter. The position peaked at $292K in Q1 2017. 247 funds tracked by Wall St. Rank hold SYNH as of Q2 2017.

  • Camelot Portfolios reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q2 2017 after selling out during the quarter.
  • Camelot Portfolios sold 6,370 Syneos Health, Inc. Class A Common Stock shares in Q2 2017, an estimated $292K.
  • Camelot Portfolios first reported a position in Syneos Health, Inc. Class A Common Stock in Q1 2017 and held it in 1 quarter.
  • Camelot Portfolios's Syneos Health, Inc. Class A Common Stock position peaked at $292K in Q1 2017.
  • 247 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q2 2017.

Based on Camelot Portfolios's 13F filing for Q2 2017, filed 31 Jul 2017.